Trial Profile
A Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Before and After Treatment With Desvenlafaxine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 28 Oct 2020 Status changed from recruiting to completed.
- 05 Oct 2017 Planned primary completion date changed from 1 Nov 2018 to 1 Dec 2018.
- 05 Oct 2017 Status changed from not yet recruiting to recruiting.